Nutraceuticals Versus Usual Care in the Prevention or Reduction of CIPN in Patients Treated With Docetaxel as Neoadjuvant/Adjuvant Breast Cancer Therapy

Clinical trial NCT02795572 · TERMINATED

Trial details

NCT number

NCT02795572

Sponsor

AHS Cancer Control Alberta

Status

TERMINATED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-06-27

Primary completion

2017-08-31

Enrollment

13

View on ClinicalTrials.gov